Regeneron Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Regeneron Pharmaceuticals patents 453 in total
| Status | Patent |
|---|---|
Application | Utility: HYDROPHOBIC INTERACTION CHROMATOGRAPHY-COUPLED NATIVE MASS SPECTROMETRY FOR ANTIBODY ANALYSIS Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: METHODS FOR REDUCING OR ELIMINATING THE NEED FOR LIPOPROTEIN APHERESIS IN PATIENTS WITH HYPERLIPIDEMIA BY ADMINISTERING ALIROCUMAB Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: NON-HUMAN ANIMALS THAT MAKE SINGLE DOMAIN BINDING PROTEINS Filling date: 13 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 13 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: SINGLE CELL RNA-SEQ DATA PROCESSING Filling date: 13 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: ANTI-PTCRA ANTIBODY-DRUG CONJUGATES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: METABOLICALLY OPTIMIZED CELL CULTURE Filling date: 13 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: VEGF Antagonist Formulations Filling date: 13 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: Methods of Treating Inflammatory Conditions Filling date: 13 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: LC-MS METHODS FOR ANTIBODY ISOTYPING AND QUANTIFICATION Filling date: 13 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING Filling date: 13 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS DELIVERED BY LIPID NANOPARTICLES Filling date: 13 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN HEAVY CHAIN SEQUENCES Filling date: 13 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: ANTI-CD63 ANTIBODIES, CONJUGATES, AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: RODENTS HAVING A HUMANIZED TMPRSS GENE Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: HUMANIZED T CELL CO-RECEPTOR MICE Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: Cell Culture Medium for Eukaryotic Cells Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: Single Immunoglobulin Interleukin-1 Receptor Related (SIGIRR) Variants And Uses Thereof Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA Filling date: 13 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: METHOD OF AVERTING OPIOID ADDICTION Filling date: 13 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: GENETICALLY MODIFIED T CELL RECEPTOR MICE Filling date: 13 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: HUMAN ANTIBODIES TO BET V 1 AND METHODS OF USE THEREOF Filling date: 13 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: FORMULATION OPTIMIZATION FOR BISPECIFIC ANTIBODIES Filling date: 13 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES Filling date: 13 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof Filling date: 13 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: HIGH CONCENTRATION ANTI-C5 FORMULATIONS Filling date: 13 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof Filling date: 13 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: Anti-CTLA-4 Antibodies and Uses Thereof Filling date: 13 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: NOVEL ANTIGEN BINDING MOLECULE FORMATS Filling date: 13 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 13 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 13 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: STEROIDS AND PROTEIN-CONJUGATES THEREOF Filling date: 13 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS FOR QUANTITATING INDIVIDUAL ANTIBODIES FROM A MIXTURE Filling date: 13 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS Filling date: 13 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: MEDICAL DEVICE PACKAGING AND RELATED METHODS Filling date: 13 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 13 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: Methods for Quantifying IL-33 Filling date: 13 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 13 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN Filling date: 13 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATIONS AND METHODS OF USE Filling date: 13 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: AFFINITY CHROMATOGRAPHY-COUPLED NATIVE MASS SPECTROMETRY FOR ANTIBODY ANALYSIS Filling date: 13 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof Filling date: 13 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Recombinant Cell Surface Capture Proteins Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METHODS AND COMPOSITIONS COMPRISING REDUCED LEVEL OF HOST CELL PROTEINS Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: MODELS OF TAUOPATHY Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Treatment Of Decreased Bone Mineral Density With Zinc And Ring Finger 3 (ZNRF3) Inhibitors Filling date: 13 Sep 2025 Issue date: 7 Jan 2021 |
Showing 150 to 200 of 453 patents.